Little pouches of nicotine sold by the brand ZYN were given the green light for marketing this week through the U.S. Food and ...
Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
Eli Lilly stock rose Monday after Zepbound received Food and Drug Administration (FDA) approval as a treatment for obstructive sleep apnea among adults with obesity.
Novo Nordisk and Lilly can't keep up with demand for their weight loss drugs such as Ozempic, Wegovy and Mounjaro. But they ...
FDA authorizes Zyn nicotine pouches, citing public health benefits for adult smokers, despite concerns over flavored products ...
Current laws and regulations are not enough to protect Americans from the risks of compounded versions of popular weight loss ...
In a rare move, the FDA recommended a minimum of 5% weight-loss for drug developers seeking to establish the efficacy of ...
The region’s largest health insurer said it will only cover the drug for its FDA-approved uses ... diabetes drugs for the purposes of weight loss. Independence Blue Cross said starting Jan ...
Nicole Albanese, PharmD, discusses the science behind weight-loss drugs, their potential to treat other addictions as well as ...